Northwire Canada EditionMonday, November 9, 2026
Sign inSubscribe
Northwire
⌕
Gold 4,118.20 +1.1% Silver 52.63 +1.3% Copper 6.35 +1.8% Oil 87.64 −3.5% Palladium 1,020.00 +0.3% PX 0.140 −3.5% IVS 0.250 +2.0% SCD 0.150 +3.5% UCU 2.31 +7.9% KAPA 0.105 +0.0% AFM 1.28 +5.3% BONE 0.035 −12.5% EM 4.30 +0.0% BKM 4.05 +1.2% SGO 0.175 +16.7% BNKR 2.73 +4.2% TECT 1.68 +10.5% MKA 0.650 +0.0% BEX 0.070 +0.0% RTH 0.035 +0.0% GBU 0.085 +13.3% Gold 4,118.20 +1.1% Silver 52.63 +1.3% Copper 6.35 +1.8% Oil 87.64 −3.5% Palladium 1,020.00 +0.3% PX 0.140 −3.5% IVS 0.250 +2.0% SCD 0.150 +3.5% UCU 2.31 +7.9% KAPA 0.105 +0.0% AFM 1.28 +5.3% BONE 0.035 −12.5% EM 4.30 +0.0% BKM 4.05 +1.2% SGO 0.175 +16.7% BNKR 2.73 +4.2% TECT 1.68 +10.5% MKA 0.650 +0.0% BEX 0.070 +0.0% RTH 0.035 +0.0% GBU 0.085 +13.3%
M&A / Property

Canstar Options Golden Baie; Will Receive Initial 15.8M Shares and $208K Cash, with Additional Equity Tranches to Follow

Canstar Offloads Golden Baie Obligations to Churchill Resources, Securing Equity Upside and Cash While Focusing on High-Grade VMS Targets

By The Northwire Desk — AI Analysis Mar 23, 2026 · 07:01 ROX · 0.06 Canstar Resources Inc.
Executive Summary

The most recent news (March 23, 2026) confirms the execution of a definitive option agreement with Churchill Resources Inc. (CRI) for the Golden Baie project. Canstar will receive an initial 15.8 million shares of CRI (approx. 5% of CRI) and $208,167 in cash to reimburse bonds. Over 24 months, Canstar can receive up to an additional 4.99% ownership in CRI in four tranches. CRI must spend $1M in the first year and $5M total over 24 months to earn 100%. Canstar retains a 0.5% NSR royalty. This follows the March 9, 2026, announcement that Canstar secured a drill permit for its flagship Mary March VMS project, with drilling slated for Summer 2026.

Material Impact
  • Financial: The Golden Baie deal is highly positive as it eliminates ~$600k in 2026 holding obligations and provides ~$1.6M in immediate equity value (based on CRI market value) plus cash. This significantly improves a balance sheet that showed a $199,833 equity deficit as of Dec 31, 2025.
  • Strategic: Canstar has successfully pivoted to a "geology-first" VMS explorer. By optioning out Golden Baie and securing an $11.5M JV with VMS Mining Corp (VMSC) for Mary March/Buchans, Canstar has offloaded the heavy lifting of exploration costs while maintaining significant upside through equity, royalties, and JV interests.
  • Operational: Securing the Mary March drill permit is a critical de-risking step. The company is now fully funded for its 2026 program through the VMSC JV, which recently delivered $1M in bridge funding.
ROX · Price
Company Overview

Canstar is a Canadian mineral explorer focused on high-grade VMS deposits in Newfoundland. Its flagship is the Mary March Project, located 20km from the historic Buchans mine (one of the world's highest-grade VMS producers). Mary March features a historic discovery hole of 9.63m @ 10.1% Zn, 0.64% Cu, 1.8% Pb, 4.2 g/t Au, and 122 g/t Ag. The company is also expanding into the Skellefte VMS district in Sweden.

Read the original news release →

More from Canstar Resources Inc.

Oct 29, 2026 · 06:35

Canstar reports narrow high-grade VMS hits from funded fall drilling, though no true width was disclosed.

Drill Results Oct 08, 2026 · 06:33

Canstar nears completion of sampling at its Skellefte project, with new drill targets pending for future exploration.

Drill Results Sep 17, 2026 · 17:05

Canstar secures bridge financing to extend its runway, though the deal underscores reliance on partner capital and asset pledges.

Financings Aug 27, 2026 · 06:31

Canstar’s Mary March massive sulphide intersection marks the widest intercept to date, though grades remain below the 1999 anchor.

Drill Results Aug 20, 2026 · 18:28

Canstar extends its bridge note to secure additional time for closing its credit facility while pursuing consolidation opportunities.

Financings Jul 21, 2026 · 07:26

Canstar accelerates Mary March drilling with VMSC funding, though the stock drifts lower due to a lack of assay results.

Financings